According to the latest report by IMARC Group, titled “Infection Control Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027, The global infection control market size reached US$ 22.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2027, exhibiting a growth rate (CAGR) of 7.74% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Industry Definition and Application:
Infection control refers to the scientific approach and practical solutions that aim to avert or control the spread of infections in healthcare settings. Numerous hospitals, clinics and laboratories use these solutions to ensure the safety of patients and healthcare workers by preventing their exposure to pathogens, including viruses, bacteria, parasites and fungi. These pathogens can commonly cause ear, eye, skin, urinary tract, lung and respiratory, stomach and intestinal, and sexually transmitted infections (STIs) among individuals through contact, sprays and splashes, inhalation, and sharps injuries. As a result, certain standard procedures are maintained by healthcare professionals to ensure patient and employee safety. Some of these practices include standard immunizations, cleaning, disinfecting and sterilizing objects and surfaces, and mandatory usage of protective clothing, including gloves, masks and surgical drapes and gowns.
Infection Control Market Trends:
The market is primarily driven by the increasing incidences of nosocomial infections on the global level. This can be attributed to rising hospital admissions, along with the increasing number of surgical procedures that make patients prone to infections. This, coupled with the increasing health consciousness among the masses, has impelled healthcare professionals to ensure strict implementation of infection control measures. The market is also driven by a considerable rise in the elderly population across the globe. Since the geriatric population is more prone to develop hospital-acquired infections (HAI), there has been a significant rise in the demand for infection control solutions. The market is further driven by the growing emphasis on food sterilization and disinfection for reducing the risks of contamination. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the need for disinfection and maintenance of proper hygiene in the healthcare sector. This, along with technological advancements in sterilization equipment and the increasing preference for outsourcing sterilization services, is expected to create a positive outlook for the market.
Furthermore, on account of the rapid spread of the coronavirus disease (COVID-19) across the globe, the World Health Organization (WHO) has issued guidelines for the prevention and control of acute respiratory diseases that includes detailed instructions pertaining to standard infection control precautions, such as disinfection and sterilization, across healthcare settings. This, in turn, is significantly boosting the uptake for masks, personal protection equipment (PPE) and sanitizers, thus contributing to the market growth. Some of the other growth-inducing factors include the launch of single-use medical nonwoven devices and the easy availability of sanitizers with high-intensity infection prevention capabilities. Looking forward, the market is expected to grow at a CAGR of 7.74% during 2022-2027.
Request Free Sample Report: https://www.imarcgroup.com/infection-control-market/requestsample
Global Infection Control Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- 3M Company,
- Advanced Sterlization Products Services Inc. (Fortive Corporation),
- Belimed AG (Metall Zug),
- Cantel Medical Corp.,
- Getinge AB, Matachana,
- Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.),
- MMM Münchener Medizin Mechanik GmbH,
- Pal International,
- Sterigenics U.S. LLC (Sotera Health Holdings LLC),
- Steris Corporation
- TSO3 Inc. (Stryker Corporation).
The report has segmented the market on region, type and end user.
Breakup by Type:
- Ultrasonic Cleaners
- Sterilization Equipment
- Heat Sterilization
- Low Temperature Sterilization
- Radiation Sterilization
- Filtration-Based Sterilization
- Contract Sterilization
- ETO Sterilization
- Gamma Sterilization
- E-Beam Sterilization
- Steam Sterilization
- Infectious Waste Disposal
- Contract Sterilization
- Sterilization Consumables
- Personal Protective Equipment
Breakup by End User:
- Hospitals and Clinics
- Medical Device Companies
- Clinical Laboratories
- Pharmaceutical Companies
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2509&flag=C
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal